Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases (Q38182068)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 December 2013

Language	Label	Description	Also known as
English	Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases	scientific article published on 31 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases (English)

1 reference

Europe PubMed Central

30 August 2017

0 references

author name string

Eun Ji Lee

1

1 reference

Europe PubMed Central

30 August 2017

Jong Hoon Park

2

1 reference

Europe PubMed Central

30 August 2017

publication date

31 December 2013

1 reference

Europe PubMed Central

30 August 2017

Genomics & Informatics

1 reference

Europe PubMed Central

30 August 2017

11

1 reference

Europe PubMed Central

30 August 2017

4

1 reference

Europe PubMed Central

30 August 2017

224-229

1 reference

Europe PubMed Central

30 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Receptor for advanced glycation end products and its involvement in inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Cellular signalling of the receptor for advanced glycation end products (RAGE).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

High mobility group box 1 and kidney diseases (Review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

The immunobiology of the receptor of advanced glycation end-products: trends and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Functions of S100 proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Transforming growth factor-β/Smad signalling in diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Aldose reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Macrophages and renal fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Cardiorenal syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

A review of the S100 proteins in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Advanced glycation end products and the kidney

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Understanding RAGE, the receptor for advanced glycation end products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

The AGE-receptor in the pathogenesis of diabetic complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

The biology of the receptor for advanced glycation end products and its ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

6 September 2017

Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

14 September 2017

S100A1 and KIT gene expressions in common subtypes of renal tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

14 September 2017

Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

28 September 2017

Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Identification, classification, and expression of RAGE gene splice variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Effects of NADPH oxidase inhibitor in diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897850

31 August 2018

Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of S-100 protein in renal cell neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of specific genes activating RAGE on polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24465234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5808/GI.2013.11.4.224

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38182068&oldid=2117002863"